Authors: KOSTARIDOU S LADIS V KATTAMIS A LARAS A HADZIYANNIS SJ

Citation: S. Kostaridou et al., HBEAG-NEGATIVE HEPATITIS-B IN A PREVIOUSLY THALASSEMIC PATIENT DURINGIMMUNOSUPPRESSIVE THERAPY FOR CHRONIC GVHD, Bone marrow transplantation, 22(9), 1998, pp. 919-921

Authors: KATTAMIS CA LADIS V

Citation: Ca. Kattamis et V. Ladis, CONVENTIONAL TREATMENT OF BETA-THALASSEMIA SYNDROMES - A PERSONAL-EXPERIENCE, International journal of pediatric hematology/oncology, 4(5), 1997, pp. 513-522

Authors: SPANOS T LADIS V PALAMIDOU F PAPASSOTIRIOU I BANAGI A PREMETIS E KATTAMIS C

Citation: T. Spanos et al., THE IMPACT OF NEOCYTE TRANSFUSION IN THE MANAGEMENT OF THALASSEMIA, Vox sanguinis, 70(4), 1996, pp. 217-223

Authors: SPANOS T LADIS V KARAGEORGA M THEODORI H TZIVARAS A PERISTERI J KATTAMIS C

Citation: T. Spanos et al., CLINICAL-EVALUATION OF DIFFERENT PREVENTI ON METHODS OF NONHEMOLYTIC TRANSFUSION REACTIONS, Transfusion clinique et biologique, 2(5), 1995, pp. 373-380

Authors: KANAVAKIS E TRAEGERSYNODINOS J TZETIS M METAXOTOUMAVROMATI A LADIS V KATTAMIS C

Citation: E. Kanavakis et al., MOLECULAR CHARACTERIZATION OF HOMOZYGOUS (HIGH HBA2) BETA-THALASSEMIA-INTERMEDIA IN GREECE, Pediatric hematology and oncology, 12(1), 1995, pp. 37-45